Advisory Board
 
 
 
Dennis Gillings, Ph.D., CBE

Dennis Gillings, Ph.D., CBE

Co-Founder and Former Executive Chairman
Quintiles




 

 
Dennis B. Gillings is Co-Founder and former Executive Chairman of Quintiles Transnational, the world’s largest biopharmaceutical services company, and  member of the Fortune 500.  He retired as Executive Chairman at the end of 2015, although he remains on its board.  Prior to founding Quintiles, Dr. Gillings was a professor of biostatistics at the University of North Carolina at Chapel Hill (UNC) for more than 15 years. Among the many honors he has received, Dr. Gillings was awarded the Commander of the Most Excellent Order of the British Empire in 2004 for services to the pharmaceutical industry.  In 2012, he received the SCRIP Lifetime Achievement Award in recognition of contributions to pharmaceuticals. In 2014, Dr. Gillings was appointed World Dementia Envoy by UK Prime Minister David Cameron. As Envoy, he chaired the World Dementia Council, working with governments to provide a global leadership role in addressing the economic, regulatory and social barriers to innovation in dementia prevention, treatment, and care. He stepped down from the role as Envoy in January, 2016, however remains an active member of the World Dementia Council.  Currently, Dr. Gillings is heavily involved in private equity through NovaQuest and GHO Capital and is President of the Dennis and Mireille Gillings Foundation.  Dr. Gillings received a BSc in Mathematics (First Class Honours) from the University of Exeter, a diploma in Mathematical Statistics from Cambridge University, and a PhD in Mathematics from the University of Exeter. He also received honorary degrees from University of North Carolina at Chapel Hill, University Southampton, University of Exeter, Kings College London, and University College London.